U.S. market Closed. Opens in 1 day 7 hours 44 minutes

CELU | Celularity Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue22.77M17.98M21.34M14.28M21.15M17.55M
Cost of Revenue16.02M19.66M9.65M4.93M6.32M6.55M
Gross Profit6.75M-1.69M11.68M9.35M14.82M11.00M
Operating Expenses199.04M146.58M159.69M87.44M1.68M1.10K
Selling, General & Admin50.58M66.02M71.34M31.34M1.68M1.10K
Research & Development30.46M78.36M88.35M52.71M46.05M29.06M
Other Operating Expenses118.00M2.19M50.75M3.39MN/AN/A
Operating Income-192.29M-25.60M-148.01M-78.09M-1.68M-1.10K
Other Expenses / Income-4.00M39.80M8.96M-61.01M7.11M2.00
Before Tax Income-196.28M14.21M-100.10M-212.93M6.55M-1.10K
Income Tax Expenses10.00K13.00K20.00K-4.70M668.23K21.30M
Net Income-196.29M14.19M-100.12M-208.23M5.88M-1.10K
Interest Expenses3.02MN/A3.17M2.35MN/AN/A
Basic Shares Outstanding17.81M15.77M12.45M9.19M2.39M35.94M
Diluted Shares Outstanding17.81M14.98M12.39M9.19M2.39M35.94M
EBITDA-183.95M23.58M-88.11M-202.41M-1.68M-1.10K
EBITDA Margin-807.81%131.19%-412.98%-1,417.60%-7.96%-0.01%
EBIT-193.27M14.21M-96.93M-210.58M6.55M21.30M
EBIT Margin-848.75%79.03%-454.31%-1,474.85%30.96%121.35%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙